Posted in | News

New Glass Building Products from PPG to be Shown at GlassBuild America 2010

PPG Industries (NYSE:PPG) will showcase four new products at GlassBuild America 2010: The Glass, Window & Door Expo in Las Vegas, Sept. 14-16, including:

SOLARBAN(R) R100 glass by PPG is a neutral-reflective, solar control, low-emissivity glass with a light-to-solar gain ratio of 1.79.

  • SOLARBAN(R) R100 glass, a transparent-reflective, solar control, low-emissivity glass with a proprietary hybrid coating technology, visible light transmittance (VLT) of 42 percent and a solar heat gain coefficient (SHGC) of 0.23, as well as a 1.79 light-to-solar gain (LSG) ratio – as much as 29 percent greater than that of competing transparent-reflective, solar control, low-e glasses.
  • SUNGATE(R) 400 glass, a passive low-emissivity glass with a magnetron sputtered vacuum deposition (MSVD) “soft coat” that helps commercial buildings in heating-dominated climates retain heat from the sun and reduce winter heating costs.
  • CLARVISTA(TM) shower glass, an innovative glass for shower doors and bath and shower enclosures that, with regular maintenance, looks newer longer than other shower glass products.
  • A new insulating glass technology that helps dual-pane residential insulating glass units (IGUs) achieve R-5 insulating performance. The dual-coat technology incorporates one pane of 3-millimeter Solarban 70XL glass on the second (#2) surface of the IGU and one 3-millimeter pane of Sungate 500 glass on the fourth (#4) surface, separated by a ½-inch of argon-filled space. The configuration generates a winter nighttime U-value of 0.20, providing insulating performance that is better than or equal to any competing dual-pane IGU on the market.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.